Acris Antibodies approached Pivotal Scientific seeking assistance to find a buyer. We generated both a long list and a short list of target companies, providing them with the necessary insights. After presenting these lists, Acris felt confident moving forward on its own and opted to use only the initial modules of our modular M&A services
ROCKVILLE, MD – Oct 28, 2015 – OriGene Technologies, Inc. (“OriGene”), an industry leader of genome
wide products for research and diagnostic applications, announced today that it has acquired Acris
Antibodies GmbH (“Acris Antibodies”), a provider of antibodies and other life science related products.
Acris Antibodies sells and distributes research antibodies and related life science products to research,
diagnostic and biopharmaceutical customers worldwide. The company has 16 employees with
operations in Germany and the United States.
“Acris Antibodies’ unique antibody offering complements our existing antibody portfolio, and expands
our capabilities to better serve our customers for their research antibody needs,” said Donghui Ma,
Ph.D., Sr. Vice President of OriGene Technologies. “We also see this acquisition as a great opportunity to
meet the increasing demand from our European distributors and customers for a better and faster
service, and also plan to leverage our global reach to bring Acris products to a larger customer base.”
In a related statement, Hans-Joachim Soll, Ph.D., General Manager and Founder of Acris Antibodies said,
“We believe that the joined forces of Acris’ unique strength in the antibody market and EU presence and
OriGene’s global reach will greatly enhance our ability to better meet customer needs for high quality
antibodies”.
Acris Antibodies supplies more than 364,000 antibodies and scientific research products, and will be
integrated into OriGene’s antibody business unit.
